REVELATION BIOSCIENCES, INC. Increase Decrease In Operating Lease Liability
REVELATION BIOSCIENCES, INC. (REVB) reported Increase Decrease In Operating Lease Liability of -$6.87 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- REVELATION BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$19.13K.
- REVELATION BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was $12.26K.
- REVELATION BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2023-12-31 was $0.00.
- REVELATION BIOSCIENCES, INC. increase decrease in operating lease liability for the quarter ending 2023-09-30 was $0.00.
- REVELATION BIOSCIENCES, INC. increase decrease in operating lease liability for fiscal 2025 was $5.87K.
- REVELATION BIOSCIENCES, INC. increase decrease in operating lease liability for fiscal 2023 was $0.00.
- REVELATION BIOSCIENCES, INC. increase decrease in operating lease liability for fiscal 2022 was -$16.75K.
- REVELATION BIOSCIENCES, INC. increase decrease in operating lease liability for fiscal 2021 was -$50.59K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$19.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$6.87K 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $12.26K 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $5.87K 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-23 | $0.00 derived: sum of 2 quarters · filed 2024-09-23 | $0.00 derived: sum of 3 quarters · filed 2024-09-23 | $0.00 10-K/A · filed 2024-09-23 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2024-09-23 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | $0.00 derived: sum of 3 quarters · filed 2024-09-23 | $0.00 derived: sum of 4 quarters · filed 2024-09-23 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-22 | $0.00 derived: sum of 2 quarters · filed 2024-09-23 | $0.00 derived: sum of 3 quarters · filed 2024-09-23 | $0.00 derived: sum of 4 quarters · filed 2024-09-23 |
| 2022-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-23 | $0.00 derived: sum of 2 quarters · filed 2024-09-23 | $0.00 derived: sum of 3 quarters · filed 2024-09-23 | -$16.75K 10-K/A · filed 2024-09-23 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | -$16.75K 10-Q · filed 2023-11-09 | -$33.02K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$16.75K 10-Q · filed 2023-08-11 | -$33.02K derived: sum of 3 quarters · filed 2023-08-11 | -$48.99K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$16.75K 10-Q · filed 2023-05-22 | -$33.02K derived: sum of 2 quarters · filed 2023-05-22 | -$48.99K derived: sum of 3 quarters · filed 2023-05-22 | -$59.12K derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | -$16.27K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$32.24K derived: sum of 2 quarters · filed 2023-03-30 | -$42.37K derived: sum of 3 quarters · filed 2023-03-30 | -$50.59K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$15.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$26.09K derived: sum of 2 quarters · filed 2022-11-10 | -$34.32K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$10.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$18.35K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | -$8.23K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |